Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Cash from Financing Activities (2022 - 2025)

Historic Cash from Financing Activities for Coeptis Therapeutics Holdings (COEP) over the last 4 years, with Q3 2025 value amounting to $5.1 million.

  • Coeptis Therapeutics Holdings' Cash from Financing Activities rose 24332.08% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.0 million, marking a year-over-year increase of 7857.78%. This contributed to the annual value of $5.7 million for FY2024, which is 1618.12% up from last year.
  • Latest data reveals that Coeptis Therapeutics Holdings reported Cash from Financing Activities of $5.1 million as of Q3 2025, which was up 24332.08% from $125100.0 recorded in Q2 2025.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Cash from Financing Activities peaked at $6.1 million during Q1 2025, and registered a low of -$2.7 million during Q4 2022.
  • For the 4-year period, Coeptis Therapeutics Holdings' Cash from Financing Activities averaged around $2.0 million, with its median value being $1.5 million (2024).
  • Per our database at Business Quant, Coeptis Therapeutics Holdings' Cash from Financing Activities crashed by 10373.27% in 2023 and then surged by 75577.37% in 2024.
  • Over the past 4 years, Coeptis Therapeutics Holdings' Cash from Financing Activities (Quarter) stood at -$2.7 million in 2022, then surged by 164.1% to $1.8 million in 2023, then tumbled by 58.21% to $731971.0 in 2024, then skyrocketed by 591.83% to $5.1 million in 2025.
  • Its last three reported values are $5.1 million in Q3 2025, $125100.0 for Q2 2025, and $6.1 million during Q1 2025.